Recruiting
Phase 3

Milvexian vs. Apixaban

Sponsor:

Janssen Research & Development, LLC

Code:

NCT05757869

Conditions

Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Apixaban

Placebo

Apixaban Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information